Inserm Transfert, founded in 2000, is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding. It works under a Public Service Concession Agreement (CSP).
patent families*
number of contracts and licenses*
* For the year 2025
millions of euros invested in Proof of concept
projects detected*
Serving research
The company supports Inserm research units and researchers in the process undertaken to create value from their work. Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value.
25 ans d'Inserm Transfert : un moment inoubliable pour célébrer l'innovation !
Inserm Transfert est partenaire de la 11ème journée du Snitem le 9
Inserm Transfert est partenaire de la Journée Start-up du Snitem pour cette 11ᵉ édition ! Rendez-vous incontournable de l'écosystème du dispositif médical, cet événement réunira l'ensemble des acteurs du secteur autour des jeunes ...
09/06/2026You are